Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,781 products)
- Apoptosis(6,260 products)
- Cell Cycle/Checkpoint(4,792 products)
- Chromatin/Epigenetics(2,440 products)
- Cytoskeletal Signaling(1,527 products)
- DNA Damage/DNA Repair(2,968 products)
- Endocrinology/Hormones(3,706 products)
- Enzyme(3,667 products)
- GPCR/G-Protein(9,005 products)
- Immunology and Inflammation(3,874 products)
- Influenza Virus(301 products)
- JAK/STAT signaling(414 products)
- MAPK Signaling(1,248 products)
- Membrane Transporter/Ion Channel(3,033 products)
- Metabolism(10,207 products)
- Microbiology/Virology(7,591 products)
- Neuroscience(10,382 products)
- Other Inhibitors(36,042 products)
- Oxidation-Reduction(42 products)
- PI3K/Akt/mTOR Signaling(1,444 products)
- Proteases/Proteasome(1,724 products)
- Stem Cell and Derivatives(825 products)
- Tyrosine Kinase/Adaptors(2,035 products)
- Ubiquitination(1,717 products)
Show 16 more subcategories
Found 66686 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
(S)-JDQ-443
CAS:(S)-JDQ-443, an isomer of JDQ-443, is a selective, potent oral KRAS G12C inhibitor with antitumor properties.Formula:C29H28ClN7OColor and Shape:SolidMolecular weight:526.03TRK-IN-19
TRK-IN-19 (I-10) inhibits TRKA (1.1 nM IC50) & TRKAG595R (5.3 nM), promising for cancer research.Formula:C22H26FN5O2Color and Shape:SolidMolecular weight:411.47PTP1B-IN-16
PTP1B-IN-16: selective benzimidazole inhibitor of PTP1B, Ki: 12.6 μM, potential for type 2 diabetes research.Formula:C26H18ClN3O4SColor and Shape:SolidMolecular weight:503.96Antitumor agent-50
Antitumor agent-50 (compound 1a) is a thiazolidinone.Formula:C17H14FNO3SColor and Shape:SolidMolecular weight:331.36NusB-IN-1
NusB-IN-1 (22r) is an oral bacterial rRNA inhibitor, effective against MRSA and VRSA.Formula:C21H16N2O3Color and Shape:SolidMolecular weight:344.36Xeruborbactam
CAS:QPX7728 is an of ultra-broad-spectrum boronic acid beta-lactamase.Formula:C10H8BFO4Purity:98%Color and Shape:SolidMolecular weight:221.98Aplaviroc
CAS:Aplaviroc (AK 602), a SDP derivative, is a CCR5 antagonist. With IC50s of 0.1-0.4 nM for HIV-1Ba-L, HIV-1JRFL and HIV-1MOKW.Formula:C33H43N3O6Purity:97.98% - 98.26%Color and Shape:SolidMolecular weight:577.71NYX-2925
CAS:NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. Useful for CNS disorder studies.Formula:C14H23N3O4Color and Shape:SolidMolecular weight:297.35γ-Secretase modulator 11 hydrochloride
CAS:<p>γ-Secretase modulator 11 hydrochloride is a potent, orally active γ-secretase modulator (IC50: 0.029 μM).</p>Formula:C28H23ClF2N4O2Color and Shape:SolidMolecular weight:520.96Antitumor agent-51
Antitumor agent-51 targets osteosarcoma with 21.9 nM IC50, high selectivity, and low toxicity.Formula:C23H25N5O2SColor and Shape:SolidMolecular weight:435.54PF-06815345 hydrochloride
CAS:PF-06815345 HCl is an oral, potent PCSK9 inhibitor, IC50 13.4 μM, lowers PCSK9 in mice.Formula:C27H30Cl2FN9O4Color and Shape:SolidMolecular weight:634.49Integrase-LEDGF/p75 allosteric inhibitor 1
CAS:Oral HIV-1 allosteric integrase inhibitor, blocks DNA integration, antiviral, potent against NL432 (EC50: 3.9 nM).Formula:C33H41NO6SColor and Shape:SolidMolecular weight:579.75LRRK2-IN-3
CAS:LRRK2-IN-3: potent, selective oral LRRK2 blocker, BBB-penetrant, IC50 of 0.6 nM in hPBMCs, for Parkinson's research.Formula:C25H29ClF2N6O2Color and Shape:SolidMolecular weight:518.99LY-2979165
CAS:LY-2979165 is a metabotropic glutamate receptor agonist prodrug.Formula:C13H17N5O5SColor and Shape:SolidMolecular weight:355.37Cbl-b-IN-2
CAS:Cbl-b-IN-2 is an oral E3 enzyme inhibitor for immune-modulated diseases and cancer research.Formula:C29H30F5N5O2Color and Shape:SolidMolecular weight:575.57BTK-IN-8
BTK-IN-8: potent, selective covalent BTK inhibitor; IC50=0.22 nM, Kd=0.91 nM; effective in blood CD69 cells (IC50=0.029 μM).Formula:C26H36N6O3Color and Shape:SolidMolecular weight:480.6Anticancer agent 14
Anticancer agent 14: a potent breast cancer inhibitor; induces cell death, disrupts mito. membrane potential (IC50: 0.20-0.65 μM).Formula:C29H34N2O3Color and Shape:SolidMolecular weight:458.59LY593093
CAS:LY593093 is a selective partial orthosteric agonist of M1 muscarinic acetylcholine receptor.Formula:C32H30FN3O2Purity:98%Color and Shape:SolidMolecular weight:507.6EB-0156
EB-0156: potent ER α-glucosidase inhibitor, IC50 of 0.0479/ <0.001 μM, N-substituted valerian, broad-spectrum antiviral potential.Formula:C21H32N6O7Color and Shape:SolidMolecular weight:480.51EGFR-IN-44
EGFR-IN-44: potent EGFR kinase inhibitor, orally active, IC50 4.11 nM, 33.57% bioavailability, induces apoptosis, for lung cancer study.Formula:C27H29ClN6O2SColor and Shape:SolidMolecular weight:537.08
